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Summary Developmental genetics of congenital heart diseases has evolved from analysis of
embryo sections towards molecular genetics of cardiac morphogenesis with a dynamic view
of cardiac development. Lineage analysis, transgenic animal models and retrospective clonal
analysis of the developing heart led to identiﬁcation of different cardiac lineages and their
respective roles. Genetics of congenital heart diseases has also changed from formal genetic
analysis of familial recurrences or population based analysis to screening for mutations in can-
didates genes identiﬁed in animal models. Based on these new concepts, genetic counselling in
congenital heart diseases is based on the mechanism of a given heart defect rather than on its
anatomy. Using this approach, genetic heterogeneity or intrafamilial variability of a molecular
anomaly can at least be partially explained. Close cooperation between molecular embryol-
ogists, pathologists involved in heart development and paediatric cardiologists is crucial for
further increase of knowledge in the ﬁeld of cardiac morphogenesis and genetics of cardiac
defects.
© 2008 Elsevier Masson SAS. All rights reserved.
Résumé La connaissance de l’embryologie des cardiopathies congénitales a évolué depuisMOTS CLÉS
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l’anatomie segmentaire sur coupes d’embryons. Aujourd’hui, nous disposons de réelles données
d’embryologie moléculaire permettant d’avoir une vision dynamique du cœur en développe-
ment. L’utilisation de lignées de souris transgéniques, l’analyse clonale du cœur murin
et les nouvelles études de lignage cellulaires ont permis l’identiﬁcation de deux lignages
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cardiaques contribuant à la formation du cœur ainsi qu’à la déﬁnition de leurs rôles respectifs.
La génétique des cardiopathies congénitales a elle aussi évolué depuis la génétique formelle
et l’analyse des récurrences familiales. Désormais, nous recherchons des mutations dans des
gènes candidats issus des modèles animaux. Le conseil génétique dans les formes isolées de
cardiopathies congénitales ou dans les formes familiales est aujourd’hui fondé sur l’appréciation
du ou des mécanismes à l’origine de la cardiopathie observée, et donc d’un ou de plusieurs
gènes. L’hétérogénéité génétique ou la variabilité d’expression intrafamiliale d’une anomalie
moléculaire peut ainsi être expliquée, au moins en partie. Une coopération entre spécialistes
de la morphogenèse cardiaque, anatomistes des cardiopathies congénitales et cardiologues
pédiatres est devenue indispensable au perfectionnement des connaissances et à l’identiﬁcation
de nouveaux gènes pour les malformations cardiaques chez l’homme.
© 2008 Elsevier Masson SAS. Tous droits réservés.
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Ghese last two decades have seen a wealth of new
nformation concerning heart development. Previously, our
nowledge of cardiac development was essentially based
n the analysis of series of embryo sections and three-
imensional reconstructions so as to clarify the anatomy of
ertain regions that were difﬁcult to interpret on simple
ections. The use of these techniques does not allow either
o follow the outcome of a group of cells or to accurately
istinguish the development mechanisms of a given cardiac
hamber, the atrioventricular junction or even the efferent
athway. The use of molecular techniques has revolutionised
ll these approaches. A retrospective clonal analysis of the
ardiac precursors in the mouse enabled to follow the out-
ome of a cell and all its descendants (sister cells) in the
eveloping heart [1]. This method, supported by cellular lin-
age studies [2], has helped to demonstrate that the cardiac
evelopment concept based on the ‘‘segmentation’’ of the
mbryonic heart is far from suitable. In other words, the
otion of a primitive cardiac tube cut into segments with a
redeﬁned outcome is erroneous. Today, it is asserted that
ifferent portions of a developing heart are added sequen-
ially to the primitive linear cardiac tube. The latter derives
rom the primitive embryonic heart and exclusively supplies
he cellular contingent for the future left ventricle [3]. This
aper aims to show how the concepts of cardiogenesis have
volved and how this evolution has led to analyse certain
ongenital heart diseases differently in terms of embryolog-
cal mechanisms.
ew concepts
he origins of the heart
ata taken from the retrospective clonal mouse analysis
hows that there are two cell lineages from the areas knows
s ‘‘cardiac’’, at the gastrulation stage. The ﬁrst lineage
orms the embryonic heart, formerly considered the only
tructure at the origin of the primitive cardiac tube. The
econd lineage derives from an additional ‘‘cardiac’’ area
alled the ‘‘second cardiac ﬁeld’’. We now know that the
mbryonic heart exclusively provides the precursors for the
eft ventricle and the cells from both lineages contribute to
he formation of the atria and the right ventricle. The effer-
nt pathway derives exclusively from the second cardiac
eld [4].
I
w
n
otructure of the primitive cardiac tube
he cardiac tube, connected to the embryo by the dor-
al cardiac mesoderm, has a symmetrical structure and it
s the addition of cells to its caudal end (venous pole)
nd cranial end (arterial pole or efferent pathway) which
eads to its elongation. This cellular addition participates
o this elongation and to the curved movement of the tube
alled ‘‘looping’’. This asymmetrical curve enables to cre-
te the structure of four chambers and the arterial and
enous poles. The cardiac chambers (atria and ventricles)
hen mature through a ballooning process, symmetrically
or the atria but sequentially for the ventricles. It is this
equential phenomenon for the ventricles that produces the
rimitive interventricular foramen (the initial septum) [5].
ormation of the efferent pathway
evelopment of the efferent pathway is a complex phe-
omenon that involves the cells of the neural crest,
he endocardium and the underlying myocardium. Sev-
ral simultaneous and intricate events occur, including the
pithelio-mesenchymal transformation of the endocardium
o form the endocardial cushions, the colonisation of the
xtracellular matrix by the neural crest cells providing the
ortopulmonary septation, and ﬁnally the rotation of the
yocardium from the base of the efferent pathway to bring
he vessels in line with their respective ventricle (wedging)
6].
ow do these new concepts translate into
ractice?
o understand how this cognitive research on the cardiac
orphogenesis is integrated into paediatric cardiac practice
t all stages of life, it is necessary to brieﬂy touch upon the
istory of cardiac genetics and embryology (Table 1).
enetic background and environmentn the 1980s, the recurrence of congenital heart diseases
ithin the same family and the different anatomical phe-
otypes in the affected individuals led to Nora’s hypothesis
f multifactorial inheritance of congenital heart diseases.
Genetics and embryological mechanisms of congenital heart dise
Table 1 Conceptual evolution of the genetics of con-
genital heart diseases.
Concepts Examples
Multifactorial inheritance All heart diseases
Major role of the
environment
Teratogenic: rubella,
thalidomide
Unique mechanism of
anatomically different
heart disease: one
genetic
abnormality—several
heart diseases
Deletion of chromosome
22q1.1 and conotruncal
heart diseases
Monogenic nature of many
heart diseases
Interatrial
communication,
atrioventricular canals,
tetralogy of Fallot
Failure of strategies of
partial phenocopy:
genetically different
syndrome and
non-syndrome
associated heart
diseases
Interatrial communication
and Holt-Oram syndrome
(TBX5), tetralogy of Fallot
and deletion of
chromosome22q1.1,
atrioventricular canals
and critical cardiac region
of trisomy 21
Notion of phenotype
continuum or gravity
spectrum
Bicuspid aortic valve,
aortic stenosis and
coarctation, Shone
syndrome, hypoplasia of
left heart
Variability of intrafamilial
expression for a same
molecular abnormality
Familial heart diseases of
deletion of chromosome
22q1.1
Genetic heterogeneity of
congenital heart
diseases: one
malformation—several
genes
Interatrial communication
and mutations in NKX2.5,
GATA4, MYH7
Heterogeneity of
mechanisms for a same
heart disease
Common arterial trunk:
septation disease of the
efferent pathway or of
myocardium rotation from
the base of the efferent
pathway
Redeﬁnition of the Double outlet right
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iphenotype in relation to
the mechanism
ventricles
The recurrence was explained by a risk related to ‘‘genetic
background’’ and the environment shared within the same
family [7].
One molecular abnormality—one
mechanism—one group of heterogeneous
heart diseasesExperiences including the ablation of the neural crest
cells in chick embryos, the use of quail-chick chimeric
models and then the use of ‘‘genetic’’ ablation models
of neural crest cells gave rise to the hypothesis that a
o
o
s
r
cases 61
isturbed embryonic mechanism in cardiac development
ould produce anatomically different cardiac phenotypes
hat were embryological related [8]. The example of
eart disease observed in the deletion of chromosome
2q1.1 conﬁrms this concept in humans. Indeed, the
hildren with this cytogenetic abnormality have a heart
isease that still involves the efferent pathway or the
ortic arches [9]. This concept is expressed in the follow-
ng way: one molecular abnormality—one mechanism—one
roup of heart diseases that is potentially heterogeneous
natomically but homogeneous in terms of embryological
echanism.
aemodynamic mechanisms of congenital
eart diseases
he notion of a phenotype continuum is subtly different from
he previous item. The example is that of obstructive heart
iseases of the left side heart. Since Abraham Rudolph, it
s commonly admitted that the development of heart cham-
ers and resulting vessels is related to the pattern of the
ombined foetal blood ﬂow that passes through them. Thus,
reduction in ﬂow in the left heart may lead to coarc-
ation, at one end of the spectrum, and to hypoplasia of
he left heart, at the other end [10]. The idea that these
eart diseases belonged to a same embryological group has
een perfectly demonstrated through several arguments,
amely recurrences of different severity within the same
amily, prenatal progression of obstructive left heart dis-
ases, and ﬁnally identiﬁcation of the same mutation in
OTCH1 in patients of the same family with a different
ardiac phenotype [11]. Recently, a study conducted in
ebraﬁsh conﬁrmed the relationship between the quality of
he intracardiac blood ﬂow and the future morphology of
he heart [12].
echanistic classiﬁcation of congenital heart
iseases
he segmental view of congenital heart diseases, while
emaining essential during echocardiography analysis, sim-
liﬁes the embryological and molecular approach. The use
f a mechanistic classiﬁcation proposed by Clark [13] has
lariﬁed things and many attitudes are today based on
his: indication for screening of 22q1.1 the deletion in
onotruncal heart diseases, coherent analysis of recurrences
f congenital heart diseases within families, identiﬁcation of
ew genes of congenital heart diseases, etc.
ne heart disease—several genes
great heterogeneity observed in each congenital heart dis-
ase group has made the situation more complex, but it
as also enabled the analysis of phenotype and genotype
elationships for these malformations. Again, the concept
s still reﬂected in daily practice: differential phenotype
f atrioventricular canals in relation to the karyotype
r their anatomy thereby offering a quick indication of
yndrome [14], complexity of the anatomy of pulmonary
evascularisation in pulmonary atresia with interventricular
ommunication in relation to their association with deletion
62 F. Bajolle et al.
Figure 1. One heart disease—several mechanisms—several genes. A malformation may originate from different embryology mechanisms.
A common arterial trunk may result from a participation defect of progenitors from the second cardiac ﬁeld and/or a migration defect
of the neural crest cells and/or a rotation defect of the myocardium and/or a formation abnormality of the endocardial cushions. All
these mechanisms are controlled by multiple genes (Pax3, Pitx2, Tbx1, Fgf8, Bmp. . .). The result is a concept known as ‘‘one heart
disease—several mechanisms—several genes’’. In addition, impairment of these different mechanisms may generate a broad spectrum
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sf heart diseases affecting the conotruncal region (TOF, IAA, DORV. .
pithelio-mesenchymal; IAA: interrupted aortic arch; TGA: transpo
f Fallot with pulmonary atresia; VSD: sub-arterial ventricular sept
f chromosome 22q1.1 or mutations in Jagged1 [15,16], etc.
e may therefore state one heart disease—several genes.
ne heart disease—several
echanisms—several genes
ontinuing with these new developments, the identiﬁcation
f a second cardiac ﬁeld and the use of transgenic mice have
elped to demonstrate that the transposition of the great
essels is a heart disease located in the conotruncal region,
ut not belonging to this group in the strict sense. Indeed,
urine models and the identiﬁcation in humans of laterality
ene mutations in this heart disease are proof that there may
e a segmental defect in the left—right laterality [6,17—19].
his would explain why this heart disease is not associ-
ted with 22q1.1 deletion, which is common in other types
f conotruncal heart diseases. If we develop this concept
urther, we can see that other heart diseases involving the
fferent pathway such as the double outlet right ventricles
d
a
i
a
tT: common arterial trunk; DORV: double outlet right ventricle; EM:
of the great arteries; TOF: tetralogy of Fallot; TOF&PA: tetralogy
fect.
r even the common arterial trunk are observed in these
nimal models with laterality abnormalities. We may there-
ore conclude that these malformations may originate from
ifferent embryological mechanisms, namely a septation
efect of the conotruncal region related to a neural crest
bnormality, or a rotation and alignment defect of the effer-
nt pathway on the ventricles corresponding to a segmental
efect of laterality [6]. These observations lead to the
oncept of one heart disease—several mechanisms—several
enes (Fig. 1). They explain the genetic heterogeneity of
ertain malformative heart diseases, not by chance but by
he heterogeneity of mechanisms.
The ‘‘clinical translation’’ of this cognitive progress is
igniﬁcant. It can be summarised in several points. The
escription of the cardiac phenotype must be anatomically
ccurate. It must use the segmental classiﬁcation, while
ndicating every anatomical detail that would offer guid-
nce on the mechanism of the heart disease. It is only at
his price that a suitable genetic advice may be given.
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Certain cardiac malformations are development
sequences or algorithms with a highly complex anatomical
outcome (cardiac isomerisms), but they are actually simple
since all elements of the heart disease derive from a same
morphogenetic defect. The role of the clinician is to recog-
nise these sequences so as to describe each step. Certain
heart diseases fall within a gravity spectrum such as coarc-
tation of the aorta and hypoplastic left heart syndrome.
Knowing how to look for staggered abnormalities of the left
track in this group and understanding the progressive nature
of these heart diseases that are dependent at least in part
upon foetal cardiac ﬂow is essential for screening prenatal
and postnatal worsening conditions. Certain heart diseases
may be considered as ‘‘lures’’ on the embryological front
since they correspond to the anatomical expression of
another abnormality. We can cite here the example of the
coarctation associated with the persistent left upper vena
cava which disturbs the mitral ﬂow during the foetal life.
The coarctation here is only the translation of a congenital
abnormality to the systemic venous return and not an actual
disease of the aorta.
Conclusion
We deliberately chose not to list the many genes known
in congenital heart diseases. This type of information was
recently published [20,21]. Far from being esoteric, knowl-
edge of normal cardiac development and the mechanisms
of congenital heart diseases are essential to daily practice,
as much for the daily examination of heart diseases as for
genetic counselling before birth or in the case of familial
forms.
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